Differing Impact of Sarcopenia and Frailty in Nonalcoholic Steatohepatitis and Alcoholic Liver Disease-Reference-Cited by-同舟云学术

Differing Impact of Sarcopenia and Frailty in Nonalcoholic Steatohepatitis and Alcoholic Liver Disease

Published:2019-01 Issue:1 Volume:25 Page:14-24
ISSN:1527-6465
Container-title:Liver Transplantation
language:en
Short-container-title:Liver Transpl

Author:

Bhanji Rahima A.¹,Narayanan Praveena¹,Moynagh Michael R.²,Takahashi Naoki²,Angirekula Mounika¹,Kennedy Cassie C.³,Mara Kristin C.⁴,Dierkhising Ross A.⁴,Watt Kymberly D.¹

Affiliation:

1. Divisions of Gastroenterology and Hepatology, William J. von Liebig Transplant Center Mayo Clinic Rochester MN

2. Department of Radiology Mayo Clinic Rochester MN

3. Pulmonary and Critical Care Medicine Mayo Clinic Rochester MN

4. Biomedical Statistics and Informatics Mayo Clinic Rochester MN

Publisher

Wiley

Subject

Transplantation,Hepatology,Surgery

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/lt.25346

Reference23 articles.

1. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People

2. Frailty Predicts Waitlist Mortality in Liver Transplant Candidates

3. Malnutrition and sarcopenia predict post-liver transplantation outcomes independently of the Model for End-stage Liver Disease score

4. Sarcopenia in hiding: The risk and consequence of underestimating muscle dysfunction in nonalcoholic steatohepatitis

5. Sarcopaenia is associated with NAFLD independently of obesity and insulin resistance: Nationwide surveys (KNHANES 2008–2011)

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relationship between sarcopenia and metabolic dysfunction-associated steatotic liver disease (MASLD): A systematic review and meta-analysis;Annals of Hepatology;2024-11

2. The prevalence and effects of sarcopenia in patients with metabolic dysfunction-associated steatotic liver disease (MASLD): A systematic review and meta-analysis;Clinical Nutrition;2024-09

3. Frailty and risk of metabolic dysfunction–associated steatotic liver disease and other chronic liver diseases;Journal of Hepatology;2024-08

4. Etiology-Specific Effects of Impaired Functional Status on Liver Transplant Outcomes;Digestive Diseases and Sciences;2024-07-16

5. Targeting chronic liver diseases: Molecular markers, drug delivery strategies and future perspectives;International Journal of Pharmaceutics;2024-07